Shire (SHP.L) – Rare Disease Specialist & Fat Pitch Candidate
Investment Thesis We’re appraising biopharma and rare disease specialist company, Shire, whose...
Read MorePosted by David | Aug 14, 2017 | Company Research
Investment Thesis We’re appraising biopharma and rare disease specialist company, Shire, whose...
Read MoreI’ve recently read a wonderful book by University of Toronto professor Keith E. Stanovich named...
Read MorePosted by David | Jul 30, 2017 | Learning, Learning - 2017 - July
Top 10 Compounders Over the Past 15 Years (2002-2017) How much would $1 invested on 1st January...
Read MorePosted by David | Jul 30, 2017 | Learning, Learning - 2017 - July
The Challenge Howard Marks, the accomplished investors and author of the Most Important Thing, has...
Read MorePosted by David | Jul 24, 2017 | Portfolio Holdings
Investment Thesis GOOG remains top large cap technology pick with number of growth opportunities....
Read More